Being cured of a disease and being free from its consequences are two very different things. For millions of people who have recovered from leprosy, this distinction is not just medical – it is deeply personal, social, and legal. Leprosy, also known as Hansen’s disease, can leave lasting physical damage to nerves, muscles, and limbs long after the infection has cleared. Recognising this reality, India’s Rights of Persons with Disabilities (RPwD) Act, 2016 created a specific legal category – “leprosy cured persons” – to protect those who continue to live with the disease’s aftermath. Understanding this definition is foundational to understanding the rights and support these individuals are entitled to.
Table of Contents
- What is leprosy (Hansen’s disease)?
- The RPwD Act, 2016: a rights-based framework
- The legal definition of “leprosy cured person” under the RPwD Act
- Decoding the key medical terms: paresis and loss of sensation
- Paresis
- Loss of sensation
- The significance of “no manifest deformity”
- Why the legal recognition matters
- The gap between law and reality
- The broader significance of this definition
What is leprosy (Hansen’s disease)?
Leprosy is a chronic infectious disease caused primarily by the bacterium Mycobacterium leprae. It affects the skin, the peripheral nerves, the mucosa of the upper respiratory tract, and the eyes. The disease progresses very slowly – the average incubation period is around five years, and symptoms can take up to 20 years to appear. Because of this slow progression, a person may carry the infection without knowing it for years.
The bacterium has a particular affinity for peripheral nerves. As research published in PMC explains, Mycobacterium leprae primarily infects Schwann cells in the peripheral nerves, which leads to nerve damage and the development of disabilities. This nerve involvement is what makes leprosy far more than a skin condition. Left untreated, the damage to nerves can become permanent, causing loss of sensation, muscle weakness, and deformity of the hands, feet, and eyes.
Crucially, leprosy is curable using multidrug therapy (MDT). The disease does not spread through casual contact – it requires prolonged, close contact with an untreated case. Once treatment begins, the patient stops being infectious. Despite this, leprosy remains one of the most stigmatised diseases in the world, and that stigma continues to affect individuals even after they have fully completed treatment and are medically cured.
The RPwD Act, 2016: a rights-based framework
Before the RPwD Act, 2016 came into force, India’s disability legislation was governed by the Persons with Disabilities (Equal Opportunities, Protection of Rights and Full Participation) Act, 1995, which recognised only seven disability conditions. Leprosy cured was already among them, but the legal framework was largely welfare-based rather than rights-based.
The RPwD Act, 2016 replaced the older legislation and expanded the number of recognised disability categories from 7 to 21. The new Act was enacted to fulfil India’s obligations under the United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), which India had ratified in 2007. Its guiding principles include respect for inherent dignity, non-discrimination, full and effective participation in society, and equality of opportunity.
“Leprosy cured persons” are categorised under the broader heading of locomotor disability in the Act – defined as a person’s inability to carry out activities associated with movement of self and objects, resulting from an affliction of the musculoskeletal or nervous system or both. This classification is important because it situates the challenges faced by leprosy cured persons within a recognisable medical and legal framework.
The legal definition of “leprosy cured person” under the RPwD Act
The Act provides a precise, medically grounded definition. According to the RPwD Act, 2016, a “leprosy cured person” is one who has been cured of leprosy but falls into one or more of the following conditions:
- Loss of sensation and paresis in hands, feet, eyes, or eyelids – the person suffers from loss of sensation in the hands or feet, as well as loss of sensation and paresis in the eye and eyelid.
- Deformity and paresis with functional mobility – the person has manifest deformity and paresis but still has sufficient mobility in the hands and feet to engage in normal economic activity.
- Extreme deformity combined with advanced age – the person suffers from extreme physical deformity along with advanced age, which together prevent them from taking up any gainful occupation.
This three-part definition is carefully designed to be inclusive. It captures people across a wide spectrum – from those who have no visible deformity but suffer internal nerve damage, to those whose physical condition combined with age makes earning a livelihood impossible. The law focuses not on the infection, but on its functional impact on a person’s life.
Decoding the key medical terms: paresis and loss of sensation
Two medical terms sit at the heart of the RPwD Act’s definition: paresis and loss of sensation. Understanding them is essential to understanding who qualifies as a leprosy cured person under the law.
Paresis
Paresis refers to partial muscle paralysis – a condition where muscles are weakened but not completely paralysed. In the context of leprosy, this typically affects the small muscles of the hands and feet, and the muscles controlling the eyelids. The result can be a characteristic “claw hand” or “drop foot” deformity, where the affected limb cannot be fully controlled. Paresis of the eyelid – known as lagophthalmos – prevents the eye from fully closing, leaving the cornea exposed and vulnerable to injury and blindness. As research from Johns Hopkins University on leprosy neuropathy notes, motor manifestations like paresis typically occur during the latter stages of nerve disease, and can persist long after the infection has been eliminated.
Loss of sensation
Loss of sensation, or sensory neuropathy, is one of leprosy’s most characteristic and dangerous consequences. Leprosy can cause patches of skin where the person loses all feeling – numbness that affects the ability to detect temperature, pain, or touch. This is not simply inconvenient. A person who cannot feel pain in their hands or feet may sustain injuries without noticing – a burn, a cut, or a blister – that then becomes infected, leading to progressive tissue damage, ulceration, and eventually the shortening or deformity of fingers and toes. Leprosy causes tissue loss and deformity by attacking nerve endings, and injuries sustained because of this numbness can compound disability over time.
The significance of “no manifest deformity”
One of the most legally significant aspects of the definition is that it includes people who suffer loss of sensation and paresis even when there is no visible deformity. This matters enormously. It means a person can qualify as a leprosy cured person – and be entitled to all the protections the Act offers – even if they look entirely “normal” to the outside world. Their disability is real, even when it is invisible. This is a progressive step in disability law: it moves beyond appearance and focuses on functional limitation.
Why the legal recognition matters
The inclusion of leprosy cured persons in the RPwD Act, 2016 is not symbolic. The Act provides various rights and entitlements, including equality and non-discrimination, community life, protection against cruelty and inhuman treatment, and access to justice. All of these rights are available to leprosy cured persons who hold valid disability certificates.
In practical terms, the Act entitles leprosy cured persons to employment protections, reasonable workplace accommodations, access to ongoing healthcare for managing long-term effects, rehabilitation services including physical and occupational therapy, and educational opportunities. Section 20 of the Act mandates non-discrimination in employment, and government establishments are required to provide a barrier-free environment and reasonable accommodations. Persons with benchmark disabilities – those with 40% or more of a specified disability – are also entitled to a 4% reservation in government jobs.
The need for this protection is urgent. Over 100 legal provisions under Indian law have historically discriminated against persons affected by leprosy – disqualifying them from standing for public office, denying access to public transport, and preventing them from practising certain occupations or trades. Several of these laws refer to leprosy as “incurable” and “virulent”, reflecting archaic and medically inaccurate beliefs. The RPwD Act directly challenges this legacy by affirming the legal personhood and equal rights of people who have been cured.
The gap between law and reality
Despite this legal framework, a significant gap between law and lived experience persists. States must not only repeal discriminatory laws but also actively put in place frameworks that recognise persons affected by leprosy as rights holders – with access to entitlements and opportunities on equal terms as others. This includes proper monitoring, complaints mechanisms, and education programmes for government employees.
Social stigma remains a powerful barrier. A considerable number of leprosy cases go undetected because of widespread stigma and fear of isolation from society. This fear discourages people from seeking diagnosis early – which, ironically, increases the risk of permanent nerve damage that would not have occurred with timely treatment. In India, approximately 700 to 850 leprosy colonies still exist, where affected individuals and their families live in enforced segregation, often in conditions of poverty.
Persons who have been administered with the first dose of multidrug therapy are rendered 99.99% non-infectious, eliminating any scientific basis for the exclusion or segregation of treated individuals. Yet discriminatory laws and social attitudes persist, underscoring that legal reform alone is not enough. Awareness, education, and community sensitisation are equally essential components of meaningful change.
The broader significance of this definition
The RPwD Act’s definition of “leprosy cured person” reflects a shift in how disability is understood in Indian law – from a narrow focus on visible, physical impairment to a more nuanced recognition of functional limitation. By including conditions like loss of sensation and paresis that may not be outwardly apparent, the law acknowledges a fundamental truth: disability is about the impact of a condition on a person’s life, not merely about what others can see.
For educators, healthcare professionals, policymakers, and community members, understanding this definition is the first step toward ensuring that leprosy cured persons are not doubly burdened – first by the physical consequences of the disease, and then by the indignity of exclusion. The law has drawn a clear line. The challenge now is to make that line visible and enforceable in every district hospital, every government office, and every community across the country.
What do you think? Should the definition of “leprosy cured person” under the RPwD Act be revisited to include those who face ongoing psychological and social disabilities – not just physical ones – resulting from the disease and its stigma? And given that over 100 discriminatory laws against leprosy-affected persons still exist in India, how effective can the RPwD Act’s protections truly be without comprehensive legal reform across all these statutes?
References
- https://www.who.int/news-room/fact-sheets/detail/leprosy
- https://cdnbbsr.s3waas.gov.in/s3ca0daec69b5adc880fb464895726dbdf/uploads/2022/08/2022081662.pdf
- https://www.paho.org/en/topics/leprosy-hansen-disease
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3440852/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5419007/
- https://idronline.org/article/rights/a-primer-on-indias-disability-law/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6436405/
- https://disability.trinayani.org/factsheet/leprosy-cured-person/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8604554/
- https://my.clevelandclinic.org/health/diseases/23043-leprosy-hansens-disease
- https://en.wikipedia.org/wiki/Leprosy
- https://www.ohchr.org/sites/default/files/Documents/Issues/Leprosy/impacts-covid/India.pdf
- https://vidhilegalpolicy.in/research/2015-6-7-256th-report-on-eliminating-discrimination-against-persons-affected-by-leprosy-and-their-family-members/
- https://ohrh.law.ox.ac.uk/perpetuating-discrimination-a-critical-analysis-of-the-legal-framework-surrounding-leprosy-in-india/
- https://ilepfederation.org/an-unfinished-business-discrimination-in-law-against-persons-affected-by-leprosy-and-their-family-members/
- https://blog.ipleaders.in/should-leprosy-be-included-in-rights-of-people-with-disabilities-act/
- https://oneill.law.georgetown.edu/discrimination-against-people-affected-by-leprosy-and-the-groundbreaking-case-of-vidhi-centre-for-legal-policy-vs-union-of-india-others/
Leave a Reply